Results 61 to 70 of about 37,118 (221)
Optimal Control for Tuberculosis with Exogenous Reinfection and Stigmatization [PDF]
The effect of stigmatization is hindering the control of diseases. Especially in the case of exogenous reinfection, this effect can play a massive role. We develop in this paper, based on a tuberculosis model of Feng et.al. a model with exogenous reinfection and stigmatization.
arxiv
ABSTRACT Evaluating QT prolongation induced by anti‐tuberculosis (TB) drugs in patients with active TB, who often experience tachycardia, is challenging due to the limitations of Fridericia's correction factor (QTcF) in decorrelating QTc from heart rate (HR).
Thanakorn Vongjarudech+4 more
wiley +1 more source
The paper analyzes the results of treatment in 5,396 patients with multidrug-resistant tuberculosis who were treated in the regions of the Russian Federation under the Global Fund Round 4 project based on the recommended World Health Organization ...
V. V. Testov+4 more
doaj
Introduction: In the city of Huánuco and around the world, there is a progressive increase in cases of Tuberculosis and multidrug-resistant Tuberculosis, for this reason it was necessary to identify predictors to develop multidrug-resistant Tuberculosis.
Anghella Valdivia-Gómez +5 more
doaj +1 more source
This review explores the potential of antimicrobial peptides (AMPs) and nanotechnology for the treatment of gastrointestinal infections. It analyzes bacterial resistance mechanisms, the antimicrobial actions of AMPs, and advances in nanocarriers, such as lipid‐based, polymeric, metallic, and mesoporous silica systems, that enhance peptide protection ...
Christian Shleider Carnero Canales+10 more
wiley +1 more source
Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections
This review critically evaluates fluorescent antibiotics as promising agents combining diagnostic precision with therapeutic efficacy. It highlights advances in probe design, chemical conjugation strategies, real‐time imaging applications, selective pathogen detection, and targeted therapy. The potential to combat antimicrobial resistance is discussed,
Tan Phuoc Ton+3 more
wiley +1 more source
Multidrug-resistant tuberculosis
Background With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of ...
McNerney Ruth, Zager Ellen M
doaj +1 more source
Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers
Aim Delamanid is a novel drug for the treatment of drug‐resistant tuberculosis, manufactured as 50‐mg solid and 25‐mg dispersible tablets. We evaluated the effects of dispersing the 50‐mg tablet, focusing on the relative bioavailability. Methods Delamanid, 50‐mg tablets administered dispersed vs swallowed whole, was investigated in a phase I, four ...
Yuanxi Zou+7 more
wiley +1 more source
Factors associated with multidrug-resistant tuberculosis
This case control study was conducted in selected centers of Dhaka City from March to July 2008 to determine the association of multidrug-resistant tuberculosis with the attributes related to treatment and socio-economic condition of tuberculosis ...
Md Nurul Amin+3 more
doaj
Antibiotic‐induced dysbiosis of the gut microbiota shifts host tryptophan metabolism and impairs the innate immune response during Pseudomonas aeruginosa pulmonary infection. (A) Eubiosis: During eubiosis, the intestinal microbiota metabolises tryptophan into indole metabolites, which keeps tryptophan levels within normal serum concentrations. However,
Camila Bernardo de Brito+19 more
wiley +1 more source